Current state-of-the-art and gaps in platform trials: 10 things you should know, insights from EU-PEARL
Adaptive designs; Clinical research; Patient-centred
| Autores: | , , , , , , , |
|---|---|
| Tipo de recurso: | artículo |
| Estado: | Versión publicada |
| Fecha de publicación: | 2024 |
| País: | España |
| Institución: | Departament de Salut de la Generalitat de Catalunya (DS) |
| Repositorio: | Scientia. Dipòsit d'Informació Digital del Departament de Salut |
| OAI Identifier: | oai:scientiasalut.gencat.cat:11351/11022 |
| Acceso en línea: | https://hdl.handle.net/11351/11022 |
| Access Level: | acceso abierto |
| Palabra clave: | Medicaments - Desenvolupament Medicina - Investigació ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Therapeutics::Clinical Protocols ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Investigative Techniques::Drug Development TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::terapéutica::protocolos clínicos TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::técnicas de investigación::desarrollo de medicamentos |
| id |
ES_c7e8e2d6fc75be37cced00e4a46e2cc2 |
|---|---|
| oai_identifier_str |
oai:scientiasalut.gencat.cat:11351/11022 |
| network_acronym_str |
ES |
| network_name_str |
España |
| repository_id_str |
|
| dc.title.none.fl_str_mv |
Current state-of-the-art and gaps in platform trials: 10 things you should know, insights from EU-PEARL |
| title |
Current state-of-the-art and gaps in platform trials: 10 things you should know, insights from EU-PEARL |
| spellingShingle |
Current state-of-the-art and gaps in platform trials: 10 things you should know, insights from EU-PEARL König, Franz Medicaments - Desenvolupament Medicina - Investigació ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Therapeutics::Clinical Protocols ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Investigative Techniques::Drug Development TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::terapéutica::protocolos clínicos TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::técnicas de investigación::desarrollo de medicamentos |
| title_short |
Current state-of-the-art and gaps in platform trials: 10 things you should know, insights from EU-PEARL |
| title_full |
Current state-of-the-art and gaps in platform trials: 10 things you should know, insights from EU-PEARL |
| title_fullStr |
Current state-of-the-art and gaps in platform trials: 10 things you should know, insights from EU-PEARL |
| title_full_unstemmed |
Current state-of-the-art and gaps in platform trials: 10 things you should know, insights from EU-PEARL |
| title_sort |
Current state-of-the-art and gaps in platform trials: 10 things you should know, insights from EU-PEARL |
| dc.creator.none.fl_str_mv |
König, Franz Spiertz, Cécile Millar, Daniel Machín, Núria Van Dessel, Ann Rodríguez Navarro, Sarai Genesca, Joan Pericas, Juan M |
| author |
König, Franz |
| author_facet |
König, Franz Spiertz, Cécile Millar, Daniel Machín, Núria Van Dessel, Ann Rodríguez Navarro, Sarai Genesca, Joan Pericas, Juan M |
| author_role |
author |
| author2 |
Spiertz, Cécile Millar, Daniel Machín, Núria Van Dessel, Ann Rodríguez Navarro, Sarai Genesca, Joan Pericas, Juan M |
| author2_role |
author author author author author author author |
| dc.contributor.none.fl_str_mv |
Institut Català de la Salut [Koenig F] Medical University of Vienna, Center for Medical Data Science, Vienna, Austria. [Spiertz C] Janssen Biologics BV, Leiden, the Netherlands. [Millar D] Former Employee, Janssen Research & Development, LLC, Raritan, NJ, USA. [Rodríguez-Navarro S] Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. [Machín N] TEAM-IT Research S.L., Barcelona, Spain. [Van Dessel A] Janssen Pharmaceutica NV, Beerse, Belgium. [Genescà J, Pericàs JM] Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Servei d’Hepatologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Spanish Network of Biomedical Research Centers, Digestive and Liver Diseases (CIBERehd), Madrid, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain Vall d'Hebron Barcelona Hospital Campus |
| dc.subject.none.fl_str_mv |
Medicaments - Desenvolupament Medicina - Investigació ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Therapeutics::Clinical Protocols ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Investigative Techniques::Drug Development TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::terapéutica::protocolos clínicos TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::técnicas de investigación::desarrollo de medicamentos |
| topic |
Medicaments - Desenvolupament Medicina - Investigació ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Therapeutics::Clinical Protocols ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Investigative Techniques::Drug Development TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::terapéutica::protocolos clínicos TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::técnicas de investigación::desarrollo de medicamentos |
| description |
Adaptive designs; Clinical research; Patient-centred |
| publishDate |
2024 |
| dc.date.none.fl_str_mv |
2024 2024 2024 |
| dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
| format |
article |
| status_str |
publishedVersion |
| dc.identifier.none.fl_str_mv |
https://hdl.handle.net/11351/11022 |
| url |
https://hdl.handle.net/11351/11022 |
| dc.language.none.fl_str_mv |
Inglés |
| language_invalid_str_mv |
Inglés |
| dc.relation.none.fl_str_mv |
eClinicalMedicine;67 https://doi.org/10.1016/j.eclinm.2023.102384 info:eu-repo/grantAgreement/EC/H2020/847989 |
| dc.rights.none.fl_str_mv |
Attribution-NonCommercial-NoDerivatives 4.0 International http://creativecommons.org/licenses/by-nc-nd/4.0/ info:eu-repo/semantics/openAccess |
| rights_invalid_str_mv |
Attribution-NonCommercial-NoDerivatives 4.0 International http://creativecommons.org/licenses/by-nc-nd/4.0/ |
| eu_rights_str_mv |
openAccess |
| dc.format.none.fl_str_mv |
application/pdf |
| dc.publisher.none.fl_str_mv |
Elsevier |
| publisher.none.fl_str_mv |
Elsevier |
| dc.source.none.fl_str_mv |
Scientia reponame:Scientia. Dipòsit d'Informació Digital del Departament de Salut instname:Departament de Salut de la Generalitat de Catalunya (DS) |
| instname_str |
Departament de Salut de la Generalitat de Catalunya (DS) |
| reponame_str |
Scientia. Dipòsit d'Informació Digital del Departament de Salut |
| collection |
Scientia. Dipòsit d'Informació Digital del Departament de Salut |
| repository.name.fl_str_mv |
|
| repository.mail.fl_str_mv |
|
| _version_ |
1869419219145195520 |
| spelling |
Current state-of-the-art and gaps in platform trials: 10 things you should know, insights from EU-PEARLKönig, FranzSpiertz, CécileMillar, DanielMachín, NúriaVan Dessel, AnnRodríguez Navarro, SaraiGenesca, JoanPericas, Juan MMedicaments - DesenvolupamentMedicina - InvestigacióANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Therapeutics::Clinical ProtocolsANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Investigative Techniques::Drug DevelopmentTÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::terapéutica::protocolos clínicosTÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::técnicas de investigación::desarrollo de medicamentosAdaptive designs; Clinical research; Patient-centredDiseños adaptativos; Investigación clínica; Centrada en el pacienteDissenys adaptatius; Recerca clínica; Centrada en el pacientPlatform trials bring the promise of making clinical research more efficient and more patient centric. While their use has become more widespread, including their prominent role during the COVID-19 pandemic response, broader adoption of platform trials has been limited by the lack of experience and tools to navigate the critical upfront planning required to launch such collaborative studies. The European Union-Patient-cEntric clinicAl tRial pLatform (EU-PEARL) initiative has produced new methodologies to expand the use of platform trials with an overarching infrastructure and services embedded into Integrated Research Platforms (IRPs), in collaboration with patient representatives and through consultation with U.S. Food and Drug Administration and European Medicines Agency stakeholders. In this narrative review, we discuss the outlook for platform trials in Europe, including challenges related to infrastructure, design, adaptations, data sharing and regulation. Documents derived from the EU-PEARL project, alongside a literature search including PubMed and relevant grey literature (e.g., guidance from regulatory agencies and health technology agencies) were used as sources for a multi-stage collaborative process through which the 10 more important points based on lessons drawn from the EU-PEARL project were developed and summarised as guidance for the setup of platform trials. We conclude that early involvement of critical stakeholder such as regulatory agencies or patients are critical steps in the implementation and later acceptance of platform trials. Addressing these gaps will be critical for attaining the full potential of platform trials for patients.EU-PEARL has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 853966. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.ElsevierInstitut Català de la Salut[Koenig F] Medical University of Vienna, Center for Medical Data Science, Vienna, Austria. [Spiertz C] Janssen Biologics BV, Leiden, the Netherlands. [Millar D] Former Employee, Janssen Research & Development, LLC, Raritan, NJ, USA. [Rodríguez-Navarro S] Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. [Machín N] TEAM-IT Research S.L., Barcelona, Spain. [Van Dessel A] Janssen Pharmaceutica NV, Beerse, Belgium. [Genescà J, Pericàs JM] Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Servei d’Hepatologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Spanish Network of Biomedical Research Centers, Digestive and Liver Diseases (CIBERehd), Madrid, Spain. Universitat Autònoma de Barcelona, Bellaterra, SpainVall d'Hebron Barcelona Hospital Campus202420242024info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://hdl.handle.net/11351/11022Scientiareponame:Scientia. Dipòsit d'Informació Digital del Departament de Salutinstname:Departament de Salut de la Generalitat de Catalunya (DS)IngléseClinicalMedicine;67https://doi.org/10.1016/j.eclinm.2023.102384info:eu-repo/grantAgreement/EC/H2020/847989Attribution-NonCommercial-NoDerivatives 4.0 Internationalhttp://creativecommons.org/licenses/by-nc-nd/4.0/info:eu-repo/semantics/openAccessoai:scientiasalut.gencat.cat:11351/110222026-06-12T09:38:37Z |
| score |
15.81155 |